Nano-x Imaging Ltd. income statement

In fiscal 2025, Nano-x Imaging Ltd. reported revenue of $13.0m, up 15.4% on the year before, operating income of −$78.2m (a -600.8% margin) and net income of −$75.0m, or −$1.16 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nano-x Imaging Ltd.: income statement, annual
Fiscal year	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	1	9	10	11	13
Cost of revenue	3	15	16	22	26
Gross profit	−2	−7	−7	−11	−13
Research and development	17	27	26	20	19
Selling and marketing	7	4	4	3	6
General and administrative	35	41	24	22	22
Operating income	−62	−118	−63	−57	−78
Income before tax	−62	−117	−61	−54	−77
Income tax	−0	−4	−0	−0	−2
Net income	−62	−113	−61	−54	−75
Diluted EPS	−$1.28	−$2.17	−$1.08	−$0.91	−$1.16
Diluted shares (average)	48m	52m	56m	59m	65m
EBITDA	−61	−117	−61	−56	−77

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HSDT vs NNOX MDAI vs NNOX NNOX vs NSPR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Nano-x Imaging Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Nano-x Imaging Ltd.